Pozo-Rosich P, Ailani J, Ashina M, Goadsby PJ, et al. Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023 Jul 26:S0140-6736(23)01049-8. doi: 10.1016/S0140-6736(23)01049.
PMID: 37516125